Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Cohn

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Histopathology|February 24, 2025
Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR)Jason A Jarzembowski, Fleur Webster, Klaus Beiske, et al.
Pediatric Blood & Cancer|June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COGChizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Reply to K. Beiske et alElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2018
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531Clare J Twist, Arlene Naranjo, Mary Lou Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group DatabaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Pediatric Blood & Cancer|November 18, 2020
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group projectLucas Moreno, Dongjing Guo, Meredith S Irwin, et al.
Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Pediatric Blood & Cancer|February 12, 2016
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With RecurrenceNavin Pinto, Jodi R Mayfield, Gordana Raca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Advances in Risk Classification and Treatment Strategies for NeuroblastomaNavin R Pinto, Mark A Applebaum, Samuel L Volchenboum, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Histopathology|February 24, 2025
Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR)Jason A Jarzembowski, Fleur Webster, Klaus Beiske, et al.
Pediatric Blood & Cancer|June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COGChizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Reply to K. Beiske et alElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2018
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531Clare J Twist, Arlene Naranjo, Mary Lou Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group DatabaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Pediatric Blood & Cancer|November 18, 2020
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group projectLucas Moreno, Dongjing Guo, Meredith S Irwin, et al.
Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Pediatric Blood & Cancer|February 12, 2016
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With RecurrenceNavin Pinto, Jodi R Mayfield, Gordana Raca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Advances in Risk Classification and Treatment Strategies for NeuroblastomaNavin R Pinto, Mark A Applebaum, Samuel L Volchenboum, et al.
Pageof 19